Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7459540 Fibroblast growth factor-like polypeptides

Patent 7459540 was granted and assigned to Amgen on December, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Arlen Thomason0

Benxian Liu0

Dimitry Michael Danilenko0

Date of Patent

December 2, 2008

0

Patent Application Number

096440520

Date Filed

August 23, 2000

0

Patent Citations Received

US Patent 11840558 Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

0

US Patent 12116413 Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

0

US Patent 11993637 Modified FGF-21 polypeptides with non-naturally encoded amino acids

0

US Patent 11667708 Anti-human beta klotho antibody or binding fragment thereof and methods of their use

0

Patent Primary Examiner

Anne Marie Wehbe′

0

Patent abstract

The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7459540 Fibroblast growth factor-like polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool